Literature DB >> 24719445

Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid.

Stefan Riedel1, Kar Mun Neoh2, Stephen W Eisinger2, Lisa M Dam3, Tsigereda Tekle4, Karen C Carroll5.   

Abstract

Three commercial antimicrobial susceptibility testing (AST) methods were compared to broth microdilution for testing of Staphylococcus aureus and enterococci against vancomycin, daptomycin, and linezolid. Despite high levels of categorical agreement and essential agreement, vancomycin MICs determined by MicroScan were often 1 log2 concentration higher and MICs determined by Phoenix 1 log2 concentration lower. Daptomycin MICs were 1 to 2 log2 concentrations higher by all AST methods, except Etest, potentially impacting definitive antimicrobial therapy for bloodstream infections due to these organisms.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24719445      PMCID： PMC4042782          DOI： 10.1128/JCM.00957-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  32 in total

1.  Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.

Authors:  Robert L Holmes; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-11-26       Impact factor: 5.191

2.  Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci.

Authors:  Fred C Tenover; Portia P Williams; Sheila Stocker; Angela Thompson; Leigh Ann Clark; Brandi Limbago; Roberta B Carey; Susan M Poppe; Dean Shinabarger; John E McGowan
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

Review 3.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

4.  High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

Authors:  Levita K Hidayat; Donald I Hsu; Ryan Quist; Kimberly A Shriner; Annie Wong-Beringer
Journal:  Arch Intern Med       Date:  2006-10-23

Review 5.  The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.

Authors:  Fred C Tenover; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2007-03-28       Impact factor: 9.079

6.  Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Pamela A Moise; George Sakoulas; Alan Forrest; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

7.  Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.

Authors:  Donald I Hsu; Levita K Hidayat; Ryan Quist; Janet Hindler; Asa Karlsson; Anne Yusof; Annie Wong-Beringer
Journal:  Int J Antimicrob Agents       Date:  2008-08-12       Impact factor: 5.283

8.  Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Authors:  T P Lodise; J Graves; A Evans; E Graffunder; M Helmecke; B M Lomaestro; K Stellrecht
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

9.  Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Alex Soriano; Francesc Marco; José A Martínez; Elena Pisos; Manel Almela; Veselka P Dimova; Dolores Alamo; Mar Ortega; Josefina Lopez; Josep Mensa
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272
View more
  8 in total

1.  Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.

Authors:  Clare L Kinnear; Twisha S Patel; Carol L Young; Vincent Marshall; Duane W Newton; Andrew F Read; Robert J Woods
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  From Etest to Vitek 2: Impact of Enterococcal Linezolid Susceptibility Testing Methodology on Time to Active Therapy.

Authors:  Cynthia T Nguyen; Cindy Bethel; Natasha N Pettit; Angella Charnot-Katsikas
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Essential oils and their components are a class of antifungals with potent vapour-phase-mediated anti-Candida activity.

Authors:  Adam F Feyaerts; Lotte Mathé; Walter Luyten; Stijn De Graeve; Katrien Van Dyck; Lize Broekx; Patrick Van Dijck
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

4.  Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group.

Authors:  Mark Wilcox; Suleiman Al-Obeid; Ana Gales; Roman Kozlov; José A Martínez-Orozco; Flavia Rossi; Sergey Sidorenko; Joseph Blondeau
Journal:  Future Microbiol       Date:  2019-02-06       Impact factor: 3.165

Review 5.  Methods Used for the Eradication of Staphylococcal Biofilms.

Authors:  Maciej Jaśkiewicz; Adriana Janczura; Joanna Nowicka; Wojciech Kamysz
Journal:  Antibiotics (Basel)       Date:  2019-10-04

6.  Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation.

Authors:  Rachael A Lee; Jason Goldman; Ghady Haidar; Jessica Lewis; Sana Arif; Jonathan Hand; Ricardo M La Hoz; Stephanie Pouch; Eric Holaday; Heather Clauss; Keith S Kaye; Anoma Nellore
Journal:  Open Forum Infect Dis       Date:  2022-01-22       Impact factor: 3.835

7.  Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014).

Authors:  Pieter-Jan Ceyssens; Françoise Van Bambeke; Wesley Mattheus; Sophie Bertrand; Frédéric Fux; Eddie Van Bossuyt; Sabrina Damée; Henry-Jean Nyssen; Stéphane De Craeye; Jan Verhaegen; Paul M Tulkens; Raymond Vanhoof
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

8.  In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid.

Authors:  Johanna Marcela Vanegas Múnera; Ana María Ocampo Ríos; Daniela Montoya Urrego; Judy Natalia Jiménez Quiceno
Journal:  Braz J Infect Dis       Date:  2017-04-19       Impact factor: 3.257
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.